127 related articles for article (PubMed ID: 29534591)
1. Low expression of Cyfip1 may be a potential biomarker in nasopharyngeal carcinoma.
Shi X; Chen X; Li WC; Mo LJ; Lin ZY; Li YY; Yang Z; Mo WN
Neoplasma; 2018; 65(2):292-295. PubMed ID: 29534591
[TBL] [Abstract][Full Text] [Related]
2. Circulating miR-31-5p may be a potential diagnostic biomarker in nasopharyngeal carcinoma.
Yi SJ; Liu P; Chen BL; Ou-Yang L; Xiong WM; Su JP
Neoplasma; 2019 Sep; 66(5):825-829. PubMed ID: 31129965
[TBL] [Abstract][Full Text] [Related]
3. [Over-expressions of p-eIF4E and p-4EBP1 are associated with poor prognosis in nasopharyngeal carcinoma].
Zheng J; Zhang C; Zhang Y; Pei J; Fan S
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Apr; 33(4):531-535. PubMed ID: 28395726
[TBL] [Abstract][Full Text] [Related]
4. Cyfip1 is downregulated in acute lymphoblastic leukemia and may be a potential biomarker in acute lymphoblastic leukemia.
Chen X; Qin L; Li P; Mo W
Tumour Biol; 2016 Jul; 37(7):9285-8. PubMed ID: 26779626
[TBL] [Abstract][Full Text] [Related]
5. Correlations of the expressions of c-Jun and Egr-1 proteins with clinicopathological features and prognosis of patients with nasopharyngeal carcinoma.
Zhong JT; Wang HJ; Yu J; Zhang JH; Wang SF; Yang X; Su W
Cancer Biomark; 2017; 19(2):213-220. PubMed ID: 28269757
[TBL] [Abstract][Full Text] [Related]
6. AGR2 diagnostic value in nasopharyngeal carcinoma prognosis.
Li Y; Wang W; Liu Z; Jiang Y; Lu J; Xie H; Tang F
Clin Chim Acta; 2018 Sep; 484():323-327. PubMed ID: 29269202
[TBL] [Abstract][Full Text] [Related]
7. Expression level of NUAK1 in human nasopharyngeal carcinoma and its prognostic significance.
Liu J; Tang G; Huang H; Li H; Zhang P; Xu L
Eur Arch Otorhinolaryngol; 2018 Oct; 275(10):2563-2573. PubMed ID: 30121842
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological and prognostic significance of GPx2 protein expression in nasopharyngeal carcinoma.
Liu C; He X; Wu X; Wang Z; Zuo W; Hu G
Cancer Biomark; 2017 Jul; 19(3):335-340. PubMed ID: 28453466
[TBL] [Abstract][Full Text] [Related]
9. Expression of fragile histidine triad (FHIT) and WW-domain oxidoreductase gene (WWOX) in nasopharyngeal carcinoma.
Chen X; Li P; Yang Z; Mo WN
Asian Pac J Cancer Prev; 2013; 14(1):165-71. PubMed ID: 23534718
[TBL] [Abstract][Full Text] [Related]
10. Prostate Tumor Overexpressed 1 (PTOV1) Is a Novel Prognostic Marker for Nasopharyngeal Carcinoma Progression and Poor Survival Outcomes.
Yang Q; Lin H; Wu S; Lei F; Zhu X; Song L; Hong M; Guo L
PLoS One; 2015; 10(8):e0136448. PubMed ID: 26305455
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Capacity of RASSF1A Promoter Methylation as a Biomarker in Tissue, Brushing, and Blood Samples of Nasopharyngeal Carcinoma.
Ye M; Huang T; Ni C; Yang P; Chen S
EBioMedicine; 2017 Apr; 18():32-40. PubMed ID: 28396012
[TBL] [Abstract][Full Text] [Related]
12. Joint quantitative measurement of hTERT mRNA in both peripheral blood and circulating tumor cells of patients with nasopharyngeal carcinoma and its clinical significance.
Fu X; Shen C; Wang H; Chen F; Li G; Wen Z
BMC Cancer; 2017 Jul; 17(1):479. PubMed ID: 28693532
[TBL] [Abstract][Full Text] [Related]
13. Cytoplasmic p27 is a novel prognostic biomarker and oncogenic protein for nasopharyngeal carcinoma.
Teng Y; Hu L; Yu B; Li X; Chen M; Fu X; Zhang J; Gao Y; Xu R; Zhu J
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):336-344. PubMed ID: 31884829
[TBL] [Abstract][Full Text] [Related]
14. [Expression of C-fos in nasopharyngeal carcinoma and the relationship with chemosensitivity and prognosis].
Liu YT; Zhao FP; Miao HB; Fu SZ; Zhou S; Zhang XG; Qin G
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 32(9):687-692. PubMed ID: 29771087
[No Abstract] [Full Text] [Related]
15. Five miRNAs as novel diagnostic biomarker candidates for primary nasopharyngeal carcinoma.
Tang JF; Yu ZH; Liu T; Lin ZY; Wang YH; Yang LW; He HJ; Cao J; Huang HL; Liu G
Asian Pac J Cancer Prev; 2014; 15(18):7575-81. PubMed ID: 25292031
[TBL] [Abstract][Full Text] [Related]
16. High expression of Talin-1 is associated with poor prognosis in patients with nasopharyngeal carcinoma.
Xu YF; Ren XY; Li YQ; He QM; Tang XR; Sun Y; Shao JY; Jia WH; Kang TB; Zeng MS; Liu N; Ma J
BMC Cancer; 2015 Apr; 15():332. PubMed ID: 25925041
[TBL] [Abstract][Full Text] [Related]
17. [Role of Wnt5a and LMP1 in the nasopharyngeal carcinogenesis by high-throughput tissue microarray technology].
Xu L; Zheng J; Li J; Shi L; Fan S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 37(9):865-70. PubMed ID: 23000758
[TBL] [Abstract][Full Text] [Related]
18. High expression of IMPDH2 is associated with aggressive features and poor prognosis of primary nasopharyngeal carcinoma.
Xu Y; Zheng Z; Gao Y; Duan S; Chen C; Rong J; Wang K; Yun M; Weng H; Ye S; Zhang J
Sci Rep; 2017 Apr; 7(1):745. PubMed ID: 28389646
[TBL] [Abstract][Full Text] [Related]
19. [Inactivation of PMS2 gene by promoter methylation in nasopharyngeal carcinoma].
Ni HF; Jiang B; Zhou Z; Li Y; Yuan XY; Cao XL; Huang GW
Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):812-817. PubMed ID: 27998438
[No Abstract] [Full Text] [Related]
20. [The expression and its potentially clinical significance of EphA2 in nasopharyngeal carcinoma].
Zhu G; Xiao D; Chen Q; Zhu Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Sep; 25(18):827-9, 833. PubMed ID: 22256737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
